The science
The regulatory and clinical core of this serum is colloidal oatmeal at 1 percent, which the FDA skin-protectant monograph recognises as generally safe and effective for the temporary relief of itching and irritation from eczema and dry skin — a monograph standing, not an approval. The mechanism is well characterised: colloidal oat's avenanthramides inhibit inflammatory cytokine and histamine-driven itch pathways, its beta-glucans and starches form a humectant, buffering film, and its saponins and lipids contribute mild cleansing and emollience. Controlled studies of 1 percent colloidal oatmeal creams in mild-to-moderate atopic dermatitis show reduced itch, improved barrier function and lower transepidermal water loss over two to four weeks, and a reduced need for topical steroids in some trials; those data belong to the active, and they transfer to this serum to the extent that its vehicle keeps the oat in contact with skin. The second oat kernel extract in the inactives adds prebiotic oat oligosaccharides with small studies for supporting commensal skin flora.
The base is squalane, hexyldecanol, glycerin and a low dose of dimethicone — standard, well-tolerated emollients that reduce water loss modestly in a light serum and considerably more in a cream, which is why the brand pairs it with one. The 'biomimetic complex' of rapeseed sterols and cetylhydroxyproline palmitamide has in vitro and small clinical data for supporting barrier lipid organisation; it is not a ceramide-cholesterol-fatty-acid system and should not be read as one. Bisabolol, allantoin, beta-glucan and dipotassium glycyrrhizate have decades of use and modest controlled evidence as anti-irritants. The cooling sensory blend is menthyl lactate, a TRPM8 cold-receptor agonist that produces a perceived cooling and counter-irritant effect without menthol's sting at low doses, paired with Albatrellus confluens extract, marketed for down-regulating TRPV1 sensory signalling on the strength of in vitro and supplier data; the perceived relief is real, the receptor claim is not clinically established, and cold-receptor agonists are a recognised trigger for stinging on compromised skin. Calcium chloride, the 'encapsulated calcium', contributes ions with a theoretical role in keratinocyte differentiation and no evidence at this dose. Physalis pubescens juice, ginger root and Myrothamnus flabellifolia extracts are antioxidant botanicals at supporting levels.
The brand's clinical claim — immediate moisturisation and relief of sensory irritation after 30 minutes — comes from a consumer-perception evaluation within a 33-subject, twice-daily, four-week study that has not been published; it measures reported comfort, not eczema severity scores, and is consistent with the known behaviour of a cooling oat emulsion.